medicine biomarker measurable indicator severity presence disease state may defined cellular biochemical molecular alteration cells tissues fluids measured evaluated indicate normal biological processes pathogenic processes pharmacological responses therapeutic generally biomarker anything used indicator particular disease state physiological state organism according indicator may chemical physical biological nature measurement may functional physiological biochemical cellular biomarker substance introduced organism means examine organ function aspects health example rubidium chloride used isotopic labeling evaluate perfusion heart muscle also substance whose detection indicates particular disease state example presence antibody may indicate infection specifically biomarker indicates change expression state protein correlates risk progression disease susceptibility disease given treatment biomarkers characteristic biological properties molecules detected measured parts body like blood tissue may indicate either normal diseased processes biomarkers specific cells molecules genes gene products enzymes hormones complex organ functions general characteristic changes biological structures also serve biomarkers although term biomarker relatively new biomarkers used preclinical research clinical diagnosis considerable example body temperature wellknown biomarker fever blood pressure used determine risk stroke also widely known cholesterol values biomarker risk indicator coronary vascular disease creactive protein crp marker inflammation biomarkers useful number ways including measuring progress disease evaluating effective therapeutic regimes particular cancer type establishing longterm susceptibility cancer biomarkers characterize disease progression starting earliest natural history disease biomarkers assess disease susceptibility severity allows one predict outcomes determine interventions evaluate therapeutic responses forensics epidemiologic perspective biomarkers offer unique insight relationships environmental risk parameter chemical physical biological molecular terms biomarker subset markers might discovered using genomics proteomics technologies imaging technologies biomarkers play major roles medicinal biology biomarkers help early diagnosis disease prevention drug target identification drug response etc several biomarkers identified many diseases serum ldl cholesterol blood pressure mmps tumor markers cancer necessary distinguish diseaserelated drugrelated biomarkers diseaserelated biomarkers give indication probable effect treatment patient risk indicator predictive biomarkers disease already exists diagnostic biomarker disease may develop individual case regardless type treatment prognostic biomarker predictive biomarkers help assess likely response particular treatment type prognostic markers shows progression disease without contrast drugrelated biomarkers indicate whether drug effective specific patient patients body process addition longknown parameters included objectively measured blood count numerous novel biomarkers used various medical specialties currently intensive work taking place discovery development innovative effective biomarkers new biomarkers become basis preventive medicine meaning medicine recognises diseases risk disease early takes specific countermeasures prevent development disease biomarkers also seen key personalised medicine treatments individually tailored specific patients highly efficient intervention disease processes often biomarkers indicate changes metabolic processes classic biomarker medicine laboratory parameter doctor use help make decisions making diagnosis selecting course treatment example detection certain autoantibodies patient blood reliable biomarker autoimmune disease detection rheumatoid factors important diagnostic marker rheumatoid arthritis ra diagnosis autoimmune disease antibodies bodies citrullinated proteins particular value acpas acpa stands anticitrullinated proteinpeptide antibody detected blood first symptoms ra appear thus highly valuable biomarkers early diagnosis autoimmune addition indicate disease threatens severe serious damage bones important tool doctor providing diagnosis developing treatment plan also indications acpas useful monitoring success treatment would make possible accurate use modern treatments biologicals physicians hope soon able individually tailor rheumatoid arthritis treatments patient according h√§upl et al prediction response treatment become important aim biomarker research medicine growing number new biological agents increasing pressure identify molecular parameters acpas guide therapeutic decision also help define important targets new biological agents tested clinical nih study group committed following definition characteristic objectively measured evaluated indicator normal biologic processes pathogenic processes pharmacologic responses therapeutic intervention past biomarkers primarily physiological indicators blood pressure heart rate recently biomarker becoming synonym molecular biomarker elevated prostate specific antigen molecular biomarker prostate cancer using enzyme assays liver function tests recently heightened interest relevance biomarkers oncology including role kras colorectal cancer egfrassociated cancers patients whose tumors express mutated kras gene kras protein forms part egfr signaling pathway always turned overactive egfr signaling means signaling continues downstream even upstream signaling blocked egfr inhibitor cetuximab erbitux results continued cancer cell growth proliferation testing tumor kras status wildtype vs mutant helps identify patients benefit treatment cetuximab currently effective treatment available small percentage cancer patients addition many cancer patients diagnosed stage cancer advanced far treated biomarkers ability greatly enhance cancer detection drug development process addition biomarkers enable physicians develop individualized treatment plans cancer patients thus allowing doctors tailor drugs specific patients tumor type drug response rate improve drug toxicity limited costs associated testing various therapies ensuing treatment side effects biomarkers also cover use molecular indicators environmental exposure epidemiologic studies human papilloma virus certain markers tobacco exposure nnk date biomarkers established head neck cancer chronic diseases whose treatment may require patients take medications years accurate diagnosis particularly important especially strong side effects expected treatment cases biomarkers becoming important confirm difficult diagnosis even make possible first number diseases alzheimers disease rheumatoid arthritis often begin early symptomfree phase symptomfree patients may less probability actually developing symptoms cases biomarkers help identify highrisk individuals reliably timely manner either treated onset disease soon possible order use biomarker diagnostics sample material must easy obtain possible may blood sample taken doctor urine saliva sample drop blood like diabetes patients extract fingertips regular bloodsugar monitoring rapid initiation treatment speed result obtained biomarker test critical rapid test delivers result minutes optimal makes possible physician discuss patient proceed necessary start treatment immediately test naturally detection method biomarker must accurate easy carry possible results different laboratories may differ significantly biomarker must naturally proven effectiveness diagnosis prognosis risk assessment affected diseases independent studies biomarker clinical use needs good sensitivity specificity eg good specificity eg although chosen population mind positive predictive value negative predictive value relevant biomarkers classified based different criteria based characteristics classified imaging biomarkers ct pet mri molecular biomarkers three subtypes volatile like body fluid biopsy biomarkers molecular biomarkers refer nonimaging biomarkers biophysical properties allow measurements biological samples eg plasma serum cerebrospinal fluid bronchoalveolar lavage biopsy include nucleic acidsbased biomarkers gene mutations polymorphisms quantitative gene expression analysis peptides proteins lipids metabolites small molecules biomarkers also classified based application diagnostic biomarkers ie cardiac troponin diagnosis myocardial infarction staging disease biomarkers ie brain natriuretic peptide congestive heart failure disease prognosis biomarkers cancer biomarkers biomarkers monitoring clinical response intervention hbalc antidiabetic treatment another category biomarkers includes used decision making early drug development instance pharmacodynamic pd biomarkers markers certain pharmacological response special interest dose optimization studies three broad classes biomarkers prognostic biomarkers predictive biomarkers pharmacodynamic biomarkers prognostic biomarkers give interventionindependent information disease status screening diagnosis disease monitoring prognostic biomarkers signify individuals latent period diseases natural history allowing optimal therapy prevention diseases termination prognostic biomarkers give information disease status measuring internal precursors increase decrease likelihood attaining disease example blood pressure cholesterol biomarkers prognostic biomarkers direct indirect causal pathway disease prognostic biomarker direct step causal pathway one factors products disease prognostic biomarker could indirectly associated disease related change caused exposure related unknown factor connected exposure predictive biomarkers measure effect drug tell drug expected activity offer direct information predictive biomarkers highly sensitive specific therefore increase diagnostic validity drug toxins sitespecific effect eliminating recall bias subjectivity exposed example individual exposed drug toxin concentration drug toxin within body biological effective dose provides accurate prediction effect drug toxin compared estimation measurement toxin origin external pharmacodynamic pd biomarkers measure direct interaction drug receptor pharmacodynamic biomarkers reveal drug mechanisms drug intended effect biology disease ideal biological dosing concentrations physiologic responseresistance mechanisms pharmacodynamic biomarkers particularly relevant drug mechanisms tumor cells pharmacodynamic endpoints drug interventions assessed directly tumor tissues example protein phosphorylation biomarkers indicate alterations target protein kinases activation downstream signaling biomarkers validated genetic molecular biology methods classified three molecular biomarkers defined biomarkers discovered using basic acceptable platforms genomics proteomics many genomic proteomics techniques available biomarker discovery techniques recently used found page apart genomics proteomics platforms biomarker assay techniques metabolomics lipidomics glycomics secretomics commonly used techniques identification biomarkers biomarkers classified clinical applications molecular biomarkers cellular biomarkers imaging biomarkers four main types molecular biomarkers genomic biomarkers transcriptomic biomarkers proteomic biomarkers metabolic biomarkers genomic biomarkers analyze dna identifying irregular sequences genome typically single nucleotide polymorphism genetic biomarkers particularly significant cancer cancer cell lines carry somatic mutations somatic mutations distinguishable hereditary mutations mutation every cell tumor cells making easy targets transcriptomic biomarkers analyze rna molecules solely exome transcriptomic biomarkers reveal molecular identity concentration rna specific cell population patternbased rna expression analysis provides increased diagnostic prognostic capability predicting therapeutic responses individuals example distinct rna subtypes breast cancer patients different survival proteomics permits quantitative analysis detection changes proteins protein biomarkers protein biomarkers detect variety biological changes proteinprotein interactions posttranslational modifications immunological responses cellular biomarkers allow cells isolated sorted quantified characterized morphology physiology cellular biomarkers used clinical laboratory settings discriminate large sample cells based antigens example cellular biomarker sorting technique fluorescentactivated cell imaging biomarkers allow earlier detection disease compared molecular biomarkers streamline translational research drug discovery marketplace example one could determine percent receptors drug targets shortening time money research new drug development stage imaging biomarkers also noninvasive clinical advantage molecular biomarkers imagebased biomarkers xray computed tomography ct positron emission tomography pet single photo emission computed tomography spect magnetic resonance imaging many new biomarkers developed involve imaging technology imaging biomarkers many advantages usually noninvasive produce intuitive multidimensional results yielding qualitative quantitative data usually relatively comfortable patients combined sources information useful clinicians seeking make diagnosis cardiac imaging active area biomarker research coronary angiography invasive procedure requiring catheterization long gold standard diagnosing arterial stenosis scientists doctors hope develop noninvasive techniques many believe cardiac computed tomography ct great potential area researchers still attempting overcome problems related calcium blooming phenomenon calcium deposits interfere image resolution intravascular imaging techniques involving magnetic resonance imaging mri optical coherence tomography oct near infrared spectroscopy also investigated another new imaging biomarker involves radiolabeled fludeoxyglucose positron emission tomography pet used measure body cells take glucose tracking glucose doctors find sites inflammation macrophages take glucose high levels tumors also take lot glucose imaging strategy used monitor well tracking radiolabeled glucose promising technique directly measures step known crucial inflammation tumor growth mri advantages high spatial resolution adept morphological imaging functional imaging mri several disadvantages though first mri sensitivity around moll moll compared types imaging limiting problem stems fact difference atoms high energy state low energy state small example tesla typical field strength clinical mri difference high low energy states approximately molecules per million improvements increase mr sensitivity include increasing magnetic field strength hyperpolarization via optical pumping dynamic nuclear polarization also variety signal amplification schemes based chemical exchange increase sensitivity achieve molecular imaging disease biomarkers using mri targeted mri contrast agents high specificity high relaxivity sensitivity required date many studies devoted developing targetedmri contrast agents achieve molecular imaging mri commonly peptides antibodies small ligands small protein domains affibodies applied achieve targeting enhance sensitivity contrast agents targeting moieties usually linked high payload mri contrast agents mri contrast agents high alphabetic order biomarkers used surrogate endpoints assess clinical outcomes biomarkers difficult validate require different levels validation depending intended use biomarker used measure success therapeutic intervention biomarker reflect direct effect medicine